Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH
Status:
Completed
Trial end date:
2022-02-21
Target enrollment:
Participant gender:
Summary
A Phase II, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Investigate the
Anti-oxidant Activity of Heptex in Patients with Apparent Risk Factors of Nonalcoholic
Steatohepatitis (NASH)
Phase:
Phase 2
Details
Lead Sponsor:
Natural Wellness Egypt
Collaborators:
Ain Shams University National Hepatology & Tropical Medicine Research Institute